Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 179

1.

Does treatment adherence correlates with health related quality of life? Findings from a cross sectional study.

Saleem F, Hassali MA, Shafie AA, Awad GA, Atif M, ul Haq N, Aljadhey H, Farooqui M.

BMC Public Health. 2012 Apr 30;12:318. doi: 10.1186/1471-2458-12-318.

2.

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.

Landau DA, Sun C, Rosebrock D, Herman SEM, Fein J, Sivina M, Underbayev C, Liu D, Hoellenriegel J, Ravichandran S, Farooqui MZH, Zhang W, Cibulskis C, Zviran A, Neuberg DS, Livitz D, Bozic I, Leshchiner I, Getz G, Burger JA, Wiestner A, Wu CJ.

Nat Commun. 2017 Dec 19;8(1):2185. doi: 10.1038/s41467-017-02329-y.

PMID:
29259203
3.

Measurement of Elevated IL-37 Levels in Acute Ischemic Brain Injury: A Cross-sectional Pilot Study.

Zafar A, Ikram A, Jillella DV, Kempuraj D, Khan MM, Bushnaq S, Adam H, Ortega-Gutierrez S, Quadri SA, Farooqui M, Zaheer A, Leira EC.

Cureus. 2017 Oct 11;9(10):e1767. doi: 10.7759/cureus.1767.

4.

Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.

Stabile LP, Farooqui M, Kanterewicz B, Abberbock S, Kurland BF, Diergaarde B, Siegfried JM.

J Thorac Oncol. 2017 Dec 9. pii: S1556-0864(17)33076-9. doi: 10.1016/j.jtho.2017.11.126. [Epub ahead of print]

PMID:
29233790
5.

Knowledge, Attitude and Practices Regarding Benign Testicular Disorders in the Educated Young Men of Pakistan.

Saleem D, Muneer S, Younus Khan RF, Ochani RK, Ahmed SS, Begg M, Siddiqi TJ, Abbas SR, Naseeb MW, Farooqui MO, Shaikh FH, Kirmani R, Ullah H, Fatima K.

Cureus. 2017 Aug 13;9(8):e1563. doi: 10.7759/cureus.1563.

6.

Research Associates Program: Expanding clinical research productivity with undergraduate students.

Hoonpongsimanont W, Sahota PK, Ng NN, Farooqui MJ, Chakravarthy B, Patel B, Lotfipour S.

SAGE Open Med. 2017 Sep 11;5:2050312117730245. doi: 10.1177/2050312117730245. eCollection 2017.

7.

Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo.

Rao CV, Pal S, Mohammed A, Farooqui M, Doescher MP, Asch AS, Yamada HY.

Oncotarget. 2017 May 10;8(34):57605-57621. doi: 10.18632/oncotarget.17745. eCollection 2017 Aug 22. Review.

8.

Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.

Molokie RE, Montminy C, Dionisio C, Farooqui MA, Gowhari M, Yao Y, Suarez ML, Ezenwa MO, Schlaeger JM, Wang ZJ, Wilkie DJ.

Am J Emerg Med. 2018 Jan;36(1):88-92. doi: 10.1016/j.ajem.2017.07.037. Epub 2017 Jul 13.

PMID:
28802541
9.

Effects of the 2009 Medical Cannabinoid Legalization Policy on Hospital Use for Cannabinoid Dependency and Persistent Vomiting.

Al-Shammari M, Herrera K, Liu X, Gisi B, Yamashita T, Han KT, Azab M, Mashiana H, Maklad M, Farooqui MT, Makar R, Yoo JW.

Clin Gastroenterol Hepatol. 2017 Dec;15(12):1876-1881. doi: 10.1016/j.cgh.2017.06.055. Epub 2017 Jul 12.

PMID:
28711691
10.

Posttraumatic stress disorder: a serious post-earthquake complication.

Farooqui M, Quadri SA, Suriya SS, Khan MA, Ovais M, Sohail Z, Shoaib S, Tohid H, Hassan M.

Trends Psychiatry Psychother. 2017 Apr-Jun;39(2):135-143. doi: 10.1590/2237-6089-2016-0029.

11.

Transradial vs. Transfemoral Approach in Cardiac Catheterization: A Literature Review.

Anjum I, Khan MA, Aadil M, Faraz A, Farooqui M, Hashmi A.

Cureus. 2017 Jun 3;9(6):e1309. doi: 10.7759/cureus.1309. Review.

12.

Opioids and opioid receptors orchestrate wound repair.

Wang Y, Gupta M, Poonawala T, Farooqui M, Li Y, Peng F, Rao S, Ansonoff M, Pintar JE, Gupta K.

Transl Res. 2017 Jul;185:13-23. doi: 10.1016/j.trsl.2017.05.003. Epub 2017 May 18.

PMID:
28554003
13.

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

Tarhini AA, Rafique I, Floros T, Tran P, Gooding WE, Villaruz LC, Burns TF, Friedland DM, Petro DP, Farooqui M, Gomez-Garcia J, Gaither-Davis A, Dacic S, Argiris A, Socinski MA, Stabile LP, Siegfried JM.

Cancer. 2017 Aug 1;123(15):2936-2944. doi: 10.1002/cncr.30717. Epub 2017 May 4.

PMID:
28472537
14.

Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.

Siegfried JM, Farooqui M, Rothenberger NJ, Dacic S, Stabile LP.

Oncotarget. 2017 Apr 11;8(15):24063-24076. doi: 10.18632/oncotarget.16030.

15.

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia.

Vojdeman FJ, Herman SEM, Kirkby N, Wiestner A, van T' Veer MB, Tjønnfjord GE, Itälä-Remes MA, Kimby E, Farooqui MZ, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MCJ, van Oers MHJ, Geisler CH, Niemann CU.

Leuk Lymphoma. 2017 Oct;58(10):2356-2362. doi: 10.1080/10428194.2017.1285027. Epub 2017 Feb 7.

PMID:
28278728
16.

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors.

Albitar A, Ma W, DeDios I, Estella J, Ahn I, Farooqui M, Wiestner A, Albitar M.

Oncotarget. 2017 Mar 14;8(11):17936-17944. doi: 10.18632/oncotarget.15316.

17.

Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.

Kanshana JS, Khanna V, Singh V, Jain M, Misra A, Kumar S, Farooqui M, Barthwal MK, Dikshit M.

J Cardiovasc Pharmacol. 2017 May;69(5):314-325. doi: 10.1097/FJC.0000000000000477.

PMID:
28207427
18.

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.

Herndon TM, Chen SS, Saba NS, Valdez J, Emson C, Gatmaitan M, Tian X, Hughes TE, Sun C, Arthur DC, Stetler-Stevenson M, Yuan CM, Niemann CU, Marti GE, Aue G, Soto S, Farooqui MZH, Herman SEM, Chiorazzi N, Wiestner A.

Leukemia. 2017 Jun;31(6):1340-1347. doi: 10.1038/leu.2017.11. Epub 2017 Jan 11.

19.

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.

Ahn IE, Underbayev C, Albitar A, Herman SE, Tian X, Maric I, Arthur DC, Wake L, Pittaluga S, Yuan CM, Stetler-Stevenson M, Soto S, Valdez J, Nierman P, Lotter J, Xi L, Raffeld M, Farooqui M, Albitar M, Wiestner A.

Blood. 2017 Mar 16;129(11):1469-1479. doi: 10.1182/blood-2016-06-719294. Epub 2017 Jan 3.

PMID:
28049639
20.

Antileishmanial evaluation of clubbed bis(indolyl)-pyridine derivatives: One-pot synthesis, in vitro biological evaluations and in silico ADME prediction.

Khan FA, Zaheer Z, Sangshetti JN, Patil RH, Farooqui M.

Bioorg Med Chem Lett. 2017 Feb 1;27(3):567-573. doi: 10.1016/j.bmcl.2016.12.018. Epub 2016 Dec 8.

PMID:
28003139

Supplemental Content

Support Center